BofA's Geoff Meacham on Pfizer earnings: The story is still about Covid contraction

Geoff Meacham, Bank of America Securities senior pharmaceuticals analyst, joins 'Squawk Box' to break down Pfizer's quarterly earnings results, Big Pharma 2024 outlook, and more.